1. Home /
  2. Science


Lululemon Sinks on Lower Guidance: Here's Where the Stock Could Be Headed Next

Let's delve into the charts and see what's in store for the shares.

What's Next for AbbVie Now That It Reached Our Price Target?

Let's review the charts and indicators.

Replimune Breaks Out: Could Rise 30% From Here

Let's check out the charts and indicators of this biotech name.

Struggling 3M Needs to Form a Base, but Lowered Guidance Won't Help

The diversified technology giant has been bearish for months and is likely to remain so after reducing its full-year revenue and profit forecasts.

Bearish Bets: 3 Stocks You Should Think About Shorting This Week

These recently downgraded names are displaying both quantitative and technical deterioration.

My Strategy to Buy Beam Therapeutics

Let's look at the charts and indicators.

Illumina Gets a Fundamental Bump

Here's where aggressive traders could look to probe the long side of ILMN.

For DOCS, the Writing Is on the Wall

Doximity has not finished its decline, according to the charts.

Here's Where DexCom Could Rally

Let's look at the charts and indicators.

United Therapeutics May Need to Take a Breather From the Rally

Let's look at the charts of the biotech.